These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome. Kummeling J; Stremmelaar DE; Raun N; Reijnders MRF; Willemsen MH; Ruiterkamp-Versteeg M; Schepens M; Man CCO; Gilissen C; Cho MT; McWalter K; Sinnema M; Wheless JW; Simon MEH; Genetti CA; Casey AM; Terhal PA; van der Smagt JJ; van Gassen KLI; Joset P; Bahr A; Steindl K; Rauch A; Keller E; Raas-Rothschild A; Koolen DA; Agrawal PB; Hoffman TL; Powell-Hamilton NN; Thiffault I; Engleman K; Zhou D; Bodamer O; Hoefele J; Riedhammer KM; Schwaibold EMC; Tasic V; Schubert D; Top D; Pfundt R; Higgs MR; Kramer JM; Kleefstra T Mol Psychiatry; 2021 Jun; 26(6):2013-2024. PubMed ID: 32346159 [TBL] [Abstract][Full Text] [Related]
4. Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis. Morikawa R; Watanabe Y; Igeta H; Arta RK; Ikeda M; Okazaki S; Hoya S; Saito T; Otsuka I; Egawa J; Tanifuji T; Iwata N; Someya T Psychiatry Res; 2022 Apr; 310():114481. PubMed ID: 35235885 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional Changes following Cellular Knockdown of the Schizophrenia Risk Gene Cameron D; Blake DJ; Bray NJ; Hill MJ Mol Neuropsychiatry; 2019 Apr; 5(2):109-114. PubMed ID: 31192223 [TBL] [Abstract][Full Text] [Related]
6. Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice. Mukai J; Cannavò E; Crabtree GW; Sun Z; Diamantopoulou A; Thakur P; Chang CY; Cai Y; Lomvardas S; Takata A; Xu B; Gogos JA Neuron; 2019 Nov; 104(3):471-487.e12. PubMed ID: 31606247 [TBL] [Abstract][Full Text] [Related]
7. The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Singh T; Walters JTR; Johnstone M; Curtis D; Suvisaari J; Torniainen M; Rees E; Iyegbe C; Blackwood D; McIntosh AM; Kirov G; Geschwind D; Murray RM; Di Forti M; Bramon E; Gandal M; Hultman CM; Sklar P; ; ; Palotie A; Sullivan PF; O'Donovan MC; Owen MJ; Barrett JC Nat Genet; 2017 Aug; 49(8):1167-1173. PubMed ID: 28650482 [TBL] [Abstract][Full Text] [Related]
8. The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectual Disability. Forrest MP; Hill MJ; Kavanagh DH; Tansey KE; Waite AJ; Blake DJ Schizophr Bull; 2018 Aug; 44(5):1100-1110. PubMed ID: 29228394 [TBL] [Abstract][Full Text] [Related]
9. SETD1A Mediated H3K4 Methylation and Its Role in Neurodevelopmental and Neuropsychiatric Disorders. Wang S; Bleeck A; Nadif Kasri N; Kleefstra T; van Rhijn JR; Schubert D Front Mol Neurosci; 2021; 14():772000. PubMed ID: 34803610 [TBL] [Abstract][Full Text] [Related]
10. Setd1a Insufficiency in Mice Attenuates Excitatory Synaptic Function and Recapitulates Schizophrenia-Related Behavioral Abnormalities. Nagahama K; Sakoori K; Watanabe T; Kishi Y; Kawaji K; Koebis M; Nakao K; Gotoh Y; Aiba A; Uesaka N; Kano M Cell Rep; 2020 Sep; 32(11):108126. PubMed ID: 32937141 [TBL] [Abstract][Full Text] [Related]
11. Loss-of-function variants in the schizophrenia risk gene SETD1A alter neuronal network activity in human neurons through the cAMP/PKA pathway. Wang S; Rhijn JV; Akkouh I; Kogo N; Maas N; Bleeck A; Ortiz IS; Lewerissa E; Wu KM; Schoenmaker C; Djurovic S; van Bokhoven H; Kleefstra T; Nadif Kasri N; Schubert D Cell Rep; 2022 May; 39(5):110790. PubMed ID: 35508131 [TBL] [Abstract][Full Text] [Related]
12. Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia. Blackwood DH; Thiagarajah T; Malloy P; Pickard BS; Muir WJ Neurotox Res; 2008 Oct; 14(2-3):113-20. PubMed ID: 19073419 [TBL] [Abstract][Full Text] [Related]
13. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia. Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338 [TBL] [Abstract][Full Text] [Related]
14. Case report: Lan M; Wang Y; Li S; Zhao L; Liu P; Hu W Front Neurol; 2023; 14():1278035. PubMed ID: 37928142 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia. Balakrishna T; Curtis D Schizophr Bull; 2020 Feb; 46(2):328-335. PubMed ID: 31112269 [TBL] [Abstract][Full Text] [Related]
16. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. Takata A; Xu B; Ionita-Laza I; Roos JL; Gogos JA; Karayiorgou M Neuron; 2014 May; 82(4):773-80. PubMed ID: 24853937 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics indexing genetic differences in schizophrenia: a systematic review. Taylor J; de Vries YA; van Loo HM; Kendler KS Mol Psychiatry; 2023 Feb; 28(2):883-890. PubMed ID: 36400854 [TBL] [Abstract][Full Text] [Related]
18. Psychosis and autism without functional regression in a patient with Kleefstra syndrome. Colijn MA; Lakusta CM; Marcadier JL Psychiatr Genet; 2023 Feb; 33(1):34-36. PubMed ID: 36617745 [TBL] [Abstract][Full Text] [Related]
19. Genetic architecture of schizophrenia: a review of major advancements. Legge SE; Santoro ML; Periyasamy S; Okewole A; Arsalan A; Kowalec K Psychol Med; 2021 Oct; 51(13):2168-2177. PubMed ID: 33550997 [TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]